140 related articles for article (PubMed ID: 1465877)
1. Role of maintenance immunosuppression and methylprednisolone in OKT3-induced cytokine release.
Peces R; Urra JM; Gorostidi M; López-Larrea C
Transplant Proc; 1992 Dec; 24(6):2596-9. PubMed ID: 1465877
[No Abstract] [Full Text] [Related]
2. Evidence for granulocyte activation by OKT3.
Schmaldienst S; Böhmig G; Pohanka E; Kovarik J; Zlabinger GJ
Transplant Proc; 1992 Dec; 24(6):2600-1. PubMed ID: 1465878
[No Abstract] [Full Text] [Related]
3. Low-dose OKT3 for cadaveric renal transplantation.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
[No Abstract] [Full Text] [Related]
4. Kidney transplantation in Slovenia from 1986 through 1991.
Kandus A; Buturović-Ponikvar J; Malovrh M; Bren AF
Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
[No Abstract] [Full Text] [Related]
5. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
[No Abstract] [Full Text] [Related]
6. Increased dermal expression of ICAM-1 and VCAM-1 after administration of OKT3 in man.
Buysmann S; van Diepen FN; Surachno S; Pals ST; ten Berge RJ
Clin Nephrol; 1996 Aug; 46(2):84-91. PubMed ID: 8869784
[TBL] [Abstract][Full Text] [Related]
7. Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis.
Carrier M; Jenicek M; Pelletier LC
Transplant Proc; 1992 Dec; 24(6):2586-91. PubMed ID: 1465874
[No Abstract] [Full Text] [Related]
8. DR6 compatibility and kidney graft survival.
Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
[No Abstract] [Full Text] [Related]
9. Cardiovascular effects of ATG and OKT3 in renal allograft recipients.
Spieker C; Barenbrock M; Buchholz B; Heidenreich S; Zidek W
Transplant Proc; 1992 Dec; 24(6):2594-5. PubMed ID: 1465876
[No Abstract] [Full Text] [Related]
10. Measures to improve early results in kidney transplantation.
Schweizer RT; Roper L; Hull D; Bartus S
Transplant Proc; 1992 Dec; 24(6):2729-30. PubMed ID: 1465919
[No Abstract] [Full Text] [Related]
11. Tumor necrosis factor and interleukin-6 in cerebrospinal fluid of a patient with recurrent adverse central nervous system events following OKT3.
Agarwal RK; Ostaszewski ML; Feld LG; Springate JE; Moxey-Mims MM; O'Neil KM
Transplant Proc; 1993 Apr; 25(2):2143-4. PubMed ID: 8470295
[No Abstract] [Full Text] [Related]
12. Diagnosis of viral infections under therapy with OKT3 and antithymocyte globulin.
Müller T; Sprenger H; Keuchel M; Neumann C; Ebel H; Gemsa D; Lange H
Transplant Proc; 1992 Dec; 24(6):2636-8. PubMed ID: 1334590
[No Abstract] [Full Text] [Related]
13. Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.
Morgan JD; Horsburgh T; Simpson A; Donnelly PK; Veitch PS; Bell PR
Transplant Proc; 1992 Dec; 24(6):2634-5. PubMed ID: 1334589
[No Abstract] [Full Text] [Related]
14. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
15. Chronic rejection of renal allografts with four immunosuppressive regimens.
Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
[No Abstract] [Full Text] [Related]
16. Early steroid withdrawal after renal transplantation.
Colaneri J
Nephrol Nurs J; 2006; 33(1):89-90. PubMed ID: 16538935
[No Abstract] [Full Text] [Related]
17. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406
[No Abstract] [Full Text] [Related]
18. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation.
Berthoux FC; Guerin C; Burgard G; Berthoux P; Alamartine E
Transplant Proc; 1992 Dec; 24(6):2578-82. PubMed ID: 1465872
[No Abstract] [Full Text] [Related]
19. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
Norman DJ; Kahana L; Stuart FP; Thistlethwaite JR; Shield CF; Monaco A; Dehlinger J; Wu SC; Van Horn A; Haverty TP
Transplantation; 1993 Jan; 55(1):44-50. PubMed ID: 8420063
[TBL] [Abstract][Full Text] [Related]
20. Suppression of OKT3-induced tumor necrosis factor alpha formation by pentoxifylline in renal transplant recipients.
Leimenstoll G; Zabel P; Schroeder P; Schlaak M; Niedermayer W
Transplant Proc; 1993 Feb; 25(1 Pt 1):561-3. PubMed ID: 8438414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
